3,3:17,17-bis(ethylenedioxy)androst-5-en-11β-ol | 13872-19-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: 3,3:17,17-bis(ethylenedioxy)androst-5-en-11β-ol
• 英文别名: 1′,4′,7′,8′,9′,10′,11′,12′,13′,14′,15′,16′-dodecahydro-2′H-dispiro[[1,3]dioxolane-2,3′-cyclopenta[a]phenanthrene-17′,2″-[1,3]dioxolan]-11′-ol；3,3;17,17-bis-ethanediyldioxy-androst-5-en-11β-ol；3,3;17,17-Bis-aethandiyldioxy-androst-5-en-11β-ol；(1'S,2'R,10'S,11'S,15'S,17'S)-2',15'-Dimethyldispiro[1,3-dioxolane-2,5'-tetracyclo[8.7.0.02,7.011,15]heptadecane-14',2''-[1,3]dioxolan]-7'-en-17'-ol
• CAS: 13872-19-0
• 化学式: C₂₃H₃₄O₅
• 分子量: 390.52
• InChiKey: IPPXYFCQCRCFPI-OLGWUGKESA-N

物化性质

• 熔点：
  200.5-202 °C
• 沸点：
  525.9±50.0 °C(Predicted)
• 密度：
  1.25±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  28
• 可旋转键数：
  0
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.91
• 拓扑面积：
  57.2
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  3,3:17,17-bis(ethylenedioxy)androst-5-en-11β-ol 在 溶剂黄146 作用下， 生成 4-雄烯-11β-醇-3,17-二酮
  参考文献：
  名称：

  Steroidal Cyclic Ketals. V. Transformation Products of Adrenosterone. The Synthesis of related C₁₉O₃-Steroids

  摘要：

  DOI：

  10.1021/jo50015a014
• 作为产物：
  描述：

  11-表氢化可的松 在 chromium(VI) oxide 、 lithium aluminium tetrahydride 、 硫酸 、 对甲苯磺酸 、 原甲酸三乙酯 作用下， 以 乙醚 、 丙酮 、 苯 为溶剂， 反应 2.5h， 生成 3,3:17,17-bis(ethylenedioxy)androst-5-en-11β-ol
  参考文献：
  名称：

  Synthesis of 11-substituted androstenediones and testosterones as human decidual cell growth inhibitors

  摘要：

  11 alpha-Hydroxytestosterone (1a), 11 beta-hydroxytestosterone (1b), 11 alpha-methoxytestosterone (1c), 11 beta-methoxytestosterone (1d), 11-ketotestosterone (1e), and Delta(9(11))-testosterone (1f) were synthesized from hydrocortisone (4b) or 11-epi-hydrocortisone (4a). The six target compounds, together with 11 alpha-methoxyandrostenedione (2c), 11 beta-methoxyandrostenedione, (2d) and their lead compound, testosterone (1), were found to effectively inhibit the growth and differentiation of human decidual cells in culture. There is no observable binding of these compounds to estrogen receptor of rabbit uterus. The introduction of apolar group (e.g., hydroxyl and carbonyl) to C-11 of androstenes decreases both the relative binding affinities to progesterone receptor and the inhibitory effects on human decidual cell growth, while the methylation of 11-hydroxyl group minimizes these effects. The similar effects of a polar group at C-11 of testosterone (1) on the inhibitory effects on human decidual cell growth and the relative binding affinities to progesterone receptor of rabbit uterus may suggest that one of the mechanisms of human decidual cell growth inhibition by these compounds is the anti-progestational activity of these androgens.

  DOI：

  10.1016/0039-128x(94)90027-2

文献信息

• Discovery of a Potent Steroidal Glucocorticoid Receptor Antagonist with Enhanced Selectivity against the Progesterone and Androgen Receptors (OP-3633)
  作者：Xiaohui Du、John Eksterowicz、Haiying Zhou、Yosup Rew、Liusheng Zhu、Xuelei Yan、Julio C. Medina、Tom Huang、Xi Chen、Dena Sutimantanapi、Nadine Jahchan、Wayne Kong、Jessica Sun、Tatiana Zavorotinskaya、Qiuping Ye、Valeria R. Fantin、Daqing Sun

  DOI：10.1021/acs.jmedchem.9b00711

  日期：2019.7.25

  mifepristone (1) led to the discovery of novel mifepristone derivatives with improved selectivity profile. Addition of a methyl group at the C10 position of the steroid has a significant impact on progesterone receptor (PR) and androgen receptor (AR) activity. Within this series, OP-3633 (15) emerged as a glucocorticoid receptor (GR) antagonist with increased selectivity against PR and AR, improved

  米非司酮的基于结构的修饰（1）导致发现了具有改进选择性的新型米非司酮衍生物。在类固醇的C10位置添加甲基对孕酮受体（PR）和雄激素受体（AR）活性具有重要影响。在该系列中，OP-3633（15）成为糖皮质激素受体（GR）拮抗剂，与1相比具有更高的抗PR和AR选择性，改善的细胞色素P450抑制特性以及显着改善的药代动力学特性。此外，有15个证明对GR具有实质性抑制作用GR阳性HCC1806三阴性乳腺癌异种移植模型中的转录活性。总体而言，化合物15是有前途的GR拮抗剂候选物，可用于临床评估GR抑制在逆转或预防治疗耐药性方面的影响。
• COMPLEX AND STRUCTURALLY DIVERSE COMPOUNDS
  申请人：The Board of Trustees of the University of Illinois

  公开号：US20150274638A1

  公开（公告）日：2015-10-01

  The invention provides a novel, general, and facile strategy for the creation of small molecules with high structural and stereochemical complexity. Aspects of the methods include ring system distortion reactions that are systematically applied to rapidly convert readily available natural products to structurally complex compounds with diverse molecular architectures. Through evaluation of chemical properties including fraction of sp 3 carbons, ClogP, and the number of stereogenic centers, these compounds are shown to be significantly more complex and diverse than those in standard screening collections. This approach is demonstrated with natural products (gibberellic acid, adrenosterone, and quinine) from three different structural classes, and methods are described for the application of this strategy to any suitable natural product.

  这项发明提供了一种新颖、通用且简便的策略，用于创造具有高结构和立体化学复杂性的小分子。该方法的方面包括系统地应用于快速将易得的天然产物转化为具有多样分子结构的结构复杂化合物的环系统失真反应。通过评估化学性质，包括sp3碳的分数、ClogP和立体中心的数量，这些化合物被证明比标准筛选集合中的化合物显着更复杂和多样化。这种方法是通过来自三个不同结构类别的天然产物（赤霉酸、肾上腺酮和奎宁）来展示的，并描述了将该策略应用于任何合适的天然产物的方法。
• Complex and structurally diverse compounds
  申请人：The Board of Trustees of the University of Illinois

  公开号：US10800730B2

  公开（公告）日：2020-10-13

  The invention provides a novel, general, and facile strategy for the creation of small molecules with high structural and stereochemical complexity. Aspects of the methods include ring system distortion reactions that are systematically applied to rapidly convert readily available natural products to structurally complex compounds with diverse molecular architectures. Through evaluation of chemical properties including fraction of sp3 carbons, ClogP, and the number of stereogenic centers, these compounds are shown to be significantly more complex and diverse than those in standard screening collections. This approach is demonstrated with natural products (gibberellic acid, adrenosterone, and quinine) from three different structural classes, and methods are described for the application of this strategy to any suitable natural product.

  本发明提供了一种新颖、通用和简便的策略，用于制造具有高结构和立体化学复杂性的小分子。该方法的各个方面包括系统地应用环系畸变反应，将容易获得的天然产物快速转化为具有不同分子结构的结构复杂的化合物。通过对化学特性（包括 sp3 碳的比例、ClogP 和立体中心的数量）进行评估，这些化合物的复杂性和多样性明显高于标准筛选集合中的化合物。该方法通过三种不同结构类别的天然产物（赤霉素、肾上腺甾酮和奎宁）进行了演示，并介绍了将该策略应用于任何合适的天然产物的方法。
• 6-alpha methyl 17 alkyl 9alpha fluoro 11 oxygenated 17beta hydroxy-4-androsten-3-one compounds and process
  申请人：UPJOHN CO

  公开号：US02842573A1

  公开（公告）日：1958-07-08
• Organic compounds and process
  申请人：UPJOHN CO

  公开号：US02842572A1

  公开（公告）日：1958-07-08